1. Angelini G, Russo S, Carli F, et al. Dodecanedioic acid prevents and reverses metabolic-associated liver disease and obesity and ameliorates liver fibrosis in a rodent model of diet-induced obesity. The FASEB Journal. 2024;38:e70202. doi:10.1096/fj.202402108R https://pubmed.ncbi.nlm.nih.gov/39600104/
2. Goetzman E, et al. Dietary dicarboxylic acids provide a non-storable alternative fat source that protects mice against obesity. J Clin Invest. 2024;134(12):e174186. doi: 10.1172/JCI174186 https://pubmed.ncbi.nlm.nih.gov/38687608/
3. Mingrone G, et al. Plasma clearance and oxidation of dodecanedioic acid in humans. JPEN J Parenter Enteral Nutr. 1996;20(1):38–42. doi: 10.1177/014860719602000138. https://pubmed.ncbi.nlm.nih.gov/8788261/
4. Mingrone G, Castagneto M. Medium-chain, even-numbered dicarboxylic acids as novel energy substrates: an update. Nutr Rev. 2006;64(10 pt 1):449–456. doi: 10.1111/j.1753-4887.2006.tb00175.x. https://pubmed.ncbi.nlm.nih.gov/17063926/
5. Salinari S, Bertuzzi A, Gandolfi A, Greco AV, Scarfone A, Manco M, Mingrone G. Dodecanedioic acid overcomes metabolic inflexibility in type 2 diabetic subjects. Am J Physiol Endocrinol Metab. 2006; 291:E1051–58. 10.1152/ajpendo.00631.2005 https://pubmed.ncbi.nlm.nih.gov/16787959/
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
* Results Not Typical. All discussion about results on this website are based on individual findings where each circumstance is completely unique and may not be similar or the same as you. These products are not intended to diagnose, treat, cure or prevent any disease. The information on this website or in emails is designed for educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health problems or illnesses without consulting your doctor.